Search results
Results from the WOW.Com Content Network
Emergent BioSolutions was founded on September 5, 1998, by Fuad El-Hibri, under the name BioPort, which had formerly operated as a state-owned entity named Michigan Biological Products Institute [4] and was privatized as Emergent BioSolutions in 2004.
Pleased with Canada's decision to prepare for botulinum toxin events, one of the "more likely biological threat agents", Adam Havey, executive vice president and president of the biodefense division at Emergent BioSolutions, said, "Emergent is committed to helping allied governments fulfill their preparedness needs. We expect to expand upon our ...
El-Hibri was the Emergent BioSolutions board of directors executive chairman from April 2012 until shortly before his death. He was both the board chairman and the CEO of the company from 2004 to 2012. He was the board chairman and CEO of BioPort Corporation from 1998 to 2004. Emergent acquired BioPort in 2004. [3]
Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The selling parties are mainly entities affiliated with OHA Agency, a business that provided a ...
For premium support please call: 800-290-4726 more ways to reach us
(Reuters) -The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' smallpox vaccine for use in people at high risk of mpox infection. The FDA clearance, announced ...
ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur in 2008, before selling the smallpox vaccine to Emergent Biosolutions in 2017. Six strains of vaccinia were isolated from 3,000 doses of Dryvax and found to exhibit significant variation in virulence.
Tuesday, Emergent BioSolutions Inc. (NYSE:EBS) received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States ...